News

Being conducted in Sierra Leone’s Kambia district, the EBOVAC-Salone study tests a regimen consisting of two vaccine components based on AdVac technology from Crucell Holland, one of the

LAMP-vax is a next-generation DNA vaccine which can stimulate an immune response against a particular protein, injecting the DNA encoding the protein rather than the protein itself. The

The OLE trial is designed to evaluate the long-term safety and efficacy of ALN-AT3 and provide continued dosing for people with hemophilia enrolled in the Phase I study.

The designation is based on data from the breast cancer cohort expansion of the company’s Phase I trial, which studied the efficacy and safety of abemaciclib, a cyclin-dependent

The new formulation of Copaxone is anticipated to allow for a less frequent dosing regimen for patients with RRMS in the country. Teva Global Specialty Medicines president and

Under the deal, Lonza will develop a scalable manufacturing process for Benitec’s ddRNAi-based and Adeno-Associated Virus (AAV)-delivered products specified for therapeutic use in humans. Lonza will use its

In September, FDA had granted orphan drug designation for avelumab, to treat MCC, a rare and aggressive type of skin cancer. Pfizer oncology chief medical officer and clinical

Riociguat, a soluble guanylate cyclase (sGC) stimulator, has been approved since 2013 for the treatment of adults suffering from this life-threatening disorder of the lungs. The development and

Pembrolizumab is said to be the first drug to be approved in March through the Medicines and Healthcare Products Regulatory Agency’s Early Access to Medicine Scheme (EAMS). The